Axcelis Technologies, Inc. Stock News

Axcelis (ACLS) Q2 EPS Jumps 55%

Axcelis Technologies, Inc. (NASDAQ:ACLS ) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants David Ryzhik - Senior Vice President of Investor Relations and Corporate Strategy James G. Coogan - Executive VP & CFO Russell J.

Shares of small-cap semiconductor equipment supplier Axcelis Technologies (ACLS 9.92%) rallied big on Tuesday, up 9.6% as of 3:57 p.m. ET.

Q2 Highlights: Revenue of $194.5 million GAAP Gross Margin of 44.9%, and Non-GAAP Gross Margin of 45.2% GAAP Operating Margin of 14.9% and Non-GAAP Operating Margin of 17.7% GAAP Diluted earnings per share of $0.98, and Non-GAAP Diluted earnings per share of $1.13 BEVERLY, Mass. , Aug. 5, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the se...

BEVERLY, Mass. , July 29, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences in August: The KBCM Technology Leadership Forum on Monday, August 11 th at the Montage Deer Valley, Park City, UT.

Despite a broader industry downturn that saw its revenues decline sharply, Axcelis Technologies, Inc. is expanding its gross, operating, and free cash flow margins while maintaining a robust balance sheet. Recent data indicates that the semiconductor industry is heading to a cyclical rebound later this year, potentially setting Axcelis up for a return to revenue growth. Axcelis' ion implanters ...

BEVERLY, Mass. , July 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter 2025 before the opening of the market on Tuesday, August 5, 2025.

Axcelis Technologies stands to benefit from the semiconductor industry's demand for advanced ion implantation, driven by smaller node geometries and new device architectures. Despite recent cyclical downturns impacting revenue and margins, Axcelis maintains pricing discipline and a resilient service business to buffer volatility. Axcelis' deep specialization in ion implantation gives it a techn...